Ultrasound Evaluation for Baxter VASCU-GUARD Vascular Patches Post-Endarterectomy and Complications Assessment
Completed · NCT07048067
Conditions: Carotid Endarterectomy (CEA) Surgical Patients
At a glance
- Research payments reported, 2025
- $51,960
- U.S. investigators named
- 1
- Sites paid
- 1
- Planned or actual enrollment
- 500
About the trial
- Sponsor
- The Methodist Hospital Research Institute
- Tested
- Carotid endarterectomy (CEA) (procedure)
- Dates
- Started 2023-01-01; completion 2025-02-01
- Results posted
- Not yet
VASCU-GUARD vascular patches with the new packaging have been available at the Houston Methodist Hospital since January 2023. This study is a retrospective chart review, aiming to compare the performance of Baxter VASCU-GUARD vascular patches implemented during carotid endarterectomies (CEA) prior to January 2023 and after January 2023. This study is one of a kind, as no other comparative retrospective chart review on the performance of VASCU-GUARD vascular patches from the old and new packaging has been published yet. The project will contribute to the scientific knowledge about long-term outcomes associated with the use of patch material during endarterectomies.
From ClinicalTrials.gov, last updated 2025-07-02. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Baxter Healthcare reported $51,960 in research payments for this study in 2025 (4 payments).
Products named: Hemopatch
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.